References
- Alachkar H, Santhanam R, Harb JG (2013). Silvestrol exhibits significant in vivo and in vitro antileukemic activities and inhibits FLT3 and miR-155 expressions in acute myeloid leukemia. J Hematol Oncol, 6, 21. https://doi.org/10.1186/1756-8722-6-21
- Babar IA, Cheng CJ, Booth CJ, et al (2012). Nanoparticle-based therapy in an in vivo microRNA-155 (miR-155)-dependent mouse model of lymphoma. Proc Natl Acad Sci USA, 109, 1695-704. https://doi.org/10.1073/pnas.1201516109
- Bai Y, Qiu GR, Zhou F, et al (2013). Overexpression of DICER1 induced by the upregulation of GATA1 contributes to the proliferation and apoptosis of leukemia cells. Int J Oncol, 42,1317-24.
-
Bertozzi D, Marinello J, Manzo SG, et al (2014). The natural inhibitor of DNA topoisomerase i, camptothecin, modulates HIF-
$1\alpha$ activity by changing miR expression patterns in human cancer cells. Mol Cancer Ther, 13, 239-48. - Chaulk SG, Lattanzi VJ, Hiemer SE, Fahlman RP, Varelas X (2013). The Hippo Pathway Effectors TAZ/YAP regulate dicer expression and miRNA biogenesis through Let-7. J Biol Chem, 289, 1886-91.
- Chen L, Tang Y, Wang J, Yan Z, Xu R (2013). miR-421 induces cell proliferation and apoptosis resistance in human nasopharyngeal carcinoma via downregulation of FOXO4. Biochem Biophys Res Commun, 435, 745-50. https://doi.org/10.1016/j.bbrc.2013.05.056
- Chiyomaru T, Yamamura S, Fukuhara S, et al (2013). Genistein inhibits prostate cancer cell growth by targeting miR-34a and Oncogenic HOTAIR. PLoS One, 8, 70372. https://doi.org/10.1371/journal.pone.0070372
- Feng L, Xie Y, Zhang H, Wu Y (2011). Down-regulation of NDRG2 gene expression in human colorectal cancer involves promoter methylation and microRNA-650. Biochem Biophys Res Commun, 406, 534-8. https://doi.org/10.1016/j.bbrc.2011.02.081
- Gomez-Cabello D, Adrados I, Gamarra D, et al (2013). DGCR8-mediated disruption of miRNA biogenesis induces cellular senescence in primary fibroblasts. Aging Cell, 12, 923-31. https://doi.org/10.1111/acel.12117
- Guo Y, Tian P, Yang C, et al (2013). Silencing the doublestranded RNA binding protein DGCR8 inhibits ovarian cancer cell proliferation, migration, and invasion. Pharm Res, [Epub ahead of print].
- Hao J, Zhang S, Zhou Y, et al (2011). MicroRNA 421 suppresses DPC4/Smad4 in pancreatic cancer. Biochem Biophys Res Commun, 406, 552-7. https://doi.org/10.1016/j.bbrc.2011.02.086
- Herbert KM, Pimienta G, Degregorio SJ, Alexandrov A, Steitz JA (2013). Phosphorylation of DGCR8 increases its intracellular stability and induces a progrowth miRNA profile. Cell Rep, 5, 1070-81. https://doi.org/10.1016/j.celrep.2013.10.017
- Hu H, Du L, Nagabayashi G, Seeger RC, Gatti RA (2010). ATM is down-regulated by N-Myc-regulated microRNA-421. Proc Natl Acad Sci USA, 107, 1506-11. https://doi.org/10.1073/pnas.0907763107
- Jiang Z, Guo J, Xiao B (2010). Increased expression of miR-421 in human gastric carcinoma and its clinical association. J Gastroenterol, 45, 17-23. https://doi.org/10.1007/s00535-009-0135-6
-
Johansson J, Berg T, Kurzejamska E, et al (2013). MiR-155-mediated loss of C/
$EBP\beta$ shifts the TGF-$\beta$ response from growth inhibition to epithelial-mesenchymal transition, invasion and metastasis in breast cancer. Oncogene. - Kong W, Yang H, He L, et al (2008). MicroRNA-155 is regulated by the transforming growth factor beta/Smad pathway and contributes to epithelial cell plasticity by targeting RhoA. Mol Cell Biol, 28, 6773-84. https://doi.org/10.1128/MCB.00941-08
- Kopp KL, Ralfkiaer U, Gjerdrum LM, et al (2013). STAT5-mediated expression of oncogenic miR-155 in cutaneous T-cell lymphoma. Cell Cycle, 12, 1939-47. https://doi.org/10.4161/cc.24987
- Li P, Grgurevic S, Liu Z, et al (2013). Signal transducer and activator of transcription-3 induces MicroRNA-155 expression in chronic lymphocytic leukemia. PLoS One, 8, 64678. https://doi.org/10.1371/journal.pone.0064678
- Ling N, Gu J, Lei Z, et al (2013). micro RNA-155 regulates cell proliferation and invasion by targeting FOXO3a in glioma. Oncol Rep, 30, 2111-8.
- Liu Q, Chen J, Wang J, et al (2013). Putative tumor suppressor gene SEL1L was downregulated by aberrantly upregulated hsa-mir-155 in human pancreatic ductal adenocarcinoma. Mol Carcinog, [Epub ahead of print].
- Liu WJ, Zhao YP, Zhang TP, et al (2003). MLH1 as a Direct Target of MiR-155 and a Potential Predictor of Favorable Prognosis in Pancreatic Cancer. J Gastrointest Surg, 17, 1399-405.
- Mansour WY, Bogdanova NV, Kasten-Pisula U, et al (2013). Aberrant overexpression of miR-421 downregulates ATM and leads to a pronounced DSB repair defect and clinical hypersensitivity in SKX squamous cell carcinoma. Radiother Oncol, 106, 147-54. https://doi.org/10.1016/j.radonc.2012.10.020
- Mraz M, Dolezalova D, Plevova K, et al (2012). MicroRNA-650 expression is influenced by immunoglobulin gene rearrangement and affects the biology of chronic lymphocytic leukemia. Blood, 119, 2110-3. https://doi.org/10.1182/blood-2011-11-394874
- Neilsen PM, Noll JE, Mattiske S, et al (2013). Mutant p53 drives invasion in breast tumors through up-regulation of miR-155. Oncogenem, 32, 2992-3000. https://doi.org/10.1038/onc.2012.305
- Pu J, Bai D, Yang X, et al (2012). Adrenaline promotes cell proliferation and increases chemoresistance in colon cancer HT29 cells through induction of miR-155. Biochem Biophys Res Commun, 428, 210-5. https://doi.org/10.1016/j.bbrc.2012.09.126
- Qin W, Ren Q, Liu T, Huang Y, Wang J. MicroRNA-155 is a novel suppressor of ovarian cancer-initiating cells that targets CLDN1. FEBS Lett, 587, 1434-9.
- Rozovski U, Calin GA, Setoyama T, et al (2012). Signal transducer and activator of transcription (STAT)-3 regulates microRNA gene expression in chronic lymphocytic leukemia cells. Mol Cancer, 12, 50.
-
Sandhu SK, Volinia S, Costinean S, et al (2012). miR-155 targets histone deacetylase 4 (HDAC4) and impairs transcriptional activity of B-cell lymphoma 6 (BCL6) in the
$E\mu$ -miR-155 transgenic mouse model. Proc Natl Acad Sci USA, 109, 20047-52. https://doi.org/10.1073/pnas.1213764109 - Sun M, Xia R, Jin F, et al (2013). Downregulated long noncoding RNA MEG3 is associated with poor prognosis and promotes cell proliferation in gastric cancer. Tumour Biol, 35, 1065-73.
- Tang X, Wen S, Zheng D, ET AL (2013). Acetylation of drosha on the N-terminus inhibits its degradation by ubiquitination. PLoS One, 8, 72503. https://doi.org/10.1371/journal.pone.0072503
- Xhemalce B, Robson SC, Kouzarides T (2012). Human RNA methyltransferase BCDIN3D regulates microRNA processing. Cell, 151, 278-88. https://doi.org/10.1016/j.cell.2012.08.041
- Xu TP, Zhu CH, Zhang J, et al (2013). MicroRNA-155 expression has prognostic value in patients with non-small cell lung cancer and digestive system carcinomas. Asian Pac J Cancer Prev, 14, 7085-90. https://doi.org/10.7314/APJCP.2013.14.12.7085
- Yang L, Lin C, Jin C, et al (2013), Rosenfeld MG. lncRNAdependent mechanisms of androgen-receptor-regulated gene activation programs. Nature, 500, 598-602. https://doi.org/10.1038/nature12451
- Yang X, Song JH, Cheng Y, et al (2013). Long non-coding RNA HNF1A-AS1 regulates proliferation and migration in oesophageal adenocarcinoma cells. Gut.
- Yao Q, Sun JG, Ma H, et al (2014;). Monitoring microRNAs using a molecular beacon in CD133+/ CD338+ human lung adenocarcinoma-initiating A549 Cells. Asian Pac J Cancer Prev, 15, 161-6. https://doi.org/10.7314/APJCP.2014.15.1.161
- Zeng ZL, Li FJ, Gao F, Sun DS, Yao L (2013). Upregulation of miR-650 is correlated with down-regulation of ING4 and progression of hepatocellular carcinoma. J Surg Oncol, 107, 105-10. https://doi.org/10.1002/jso.23210
-
Zhang C, Zhao J, Deng H (2013).
$17\beta$ -estradiol up-regulates miR-155 expression and reduces TP53INP1 expression in MCF-7 breast cancer cells. Mol Cell Biochem, 379, 201-11. https://doi.org/10.1007/s11010-013-1642-6 - Zhang GJ, Xiao HX, Tian HP, et al (2013). Upregulation of microRNA-155 promotes the migration and invasion of colorectal cancer cells through the regulation of claudin-1 expression. Int J Mol Med, 31, 1375-80.
-
Zhang X, Li M, Zuo K, et al (2013). Upregulated miR-155 in papillary thyroid carcinoma promotes tumor growth by targeting APC and activating Wnt/
$\beta$ -Catenin signaling. J Clin Endocrinol Metab, 98, 1305-13. https://doi.org/10.1210/jc.2012-3602 - Zhang X, Zhu W, Zhang J, et al (2010). MicroRNA-650 targets ING4 to promote gastric cancer tumorigenicity. Biochem Biophys Res Commun, 395, 275-80. https://doi.org/10.1016/j.bbrc.2010.04.005
- Zhang Y, Gong W, Dai S, et al (2012). Downregulation of human farnesoid X receptor by miR-421 promotes proliferation and migration of hepatocellular carcinoma cells. Mol Cancer Res, 10, 516-22. https://doi.org/10.1158/1541-7786.MCR-11-0473
- Zhang Y, Wei W, Cheng N, et al (2012). Hepatitis C virusinduced up-regulation of microRNA-155 promotes hepatocarcinogenesis by activating Wnt signaling. Hepatology, 56, 1631-40. https://doi.org/10.1002/hep.25849
- Zhang Z, Zhu Z, Watabe K, et al (2013). Negative regulation of lncRNA GAS5 by miR-21. Cell Death Differ, 20, 1558-68. https://doi.org/10.1038/cdd.2013.110
- Zhao XD, Zhang W, Liang HJ, Ji WY (2013). Overexpression of miR -155 promotes proliferation and invasion of human laryngeal squamous cell carcinoma via targeting SOCS1 and STAT3. PLoS One, 8, 56395. https://doi.org/10.1371/journal.pone.0056395
- Zheng SR, Guo GL, Zhai Q, Zou ZY, Zhang W (2013). Effects of miR-155 antisense oligonucleotide on breast carcinoma cell line MDA-MB-157 and implanted tumors. Asian Pac J Cancer Prev, 14, 2361-6. https://doi.org/10.7314/APJCP.2013.14.4.2361
- Zhong XY, Yu JH, Zhang WG, et al (2012). MicroRNA-421 functions as an oncogenic miRNA in biliary tract cancer through down-regulating farnesoid X receptor expression. Gene, 493, 44-51. https://doi.org/10.1016/j.gene.2011.11.028
- Zhou H, Xiao B, Zhou F, (2012). MiR-421 is a functional marker of circulating tumor cells in gastric cancer patients. Biomarkers, 17, 104-10. https://doi.org/10.3109/1354750X.2011.614961
Cited by
- TRAIL Based Therapy: Overview of Mesenchymal Stem Cell Based Delivery and miRNA Controlled Expression of TRAIL vol.15, pp.16, 2014, https://doi.org/10.7314/APJCP.2014.15.16.6495
- MicroRNAs: Biogenesis, Roles for Carcinogenesis and as Potential Biomarkers for Cancer Diagnosis and Prognosis vol.15, pp.18, 2014, https://doi.org/10.7314/APJCP.2014.15.18.7489
- Evolution of the Mir-155 Family and Possible Targets in Cancers and the Immune System vol.15, pp.18, 2014, https://doi.org/10.7314/APJCP.2014.15.18.7547
- microRNA Expression Profile in Patients with Stage II Colorectal Cancer: A Turkish Referral Center Study vol.16, pp.5, 2015, https://doi.org/10.7314/APJCP.2015.16.5.1851
- Identification of miRNAs Potentially Involved in Bronchiolitis Obliterans Syndrome: A Computational Study vol.11, pp.8, 2016, https://doi.org/10.1371/journal.pone.0161771
- Ratio of microRNA-122/155 in isoniazid-induced acute liver injury in mice vol.12, pp.2, 2016, https://doi.org/10.3892/etm.2016.3375
- Role of Wnt/β-catenin signaling regulatory microRNAs in the pathogenesis of colorectal cancer vol.233, pp.2, 2018, https://doi.org/10.1002/jcp.25897
- Investigation of AID, Dicer, and Drosha Expressions in Patients with Chronic Lymphocytic Leukemia vol.46, pp.5, 2017, https://doi.org/10.1080/08820139.2017.1288241
- Effect of miR-155 knockdown on the reversal of doxorubicin resistance in human lung cancer A549/dox cells vol.11, pp.2, 2015, https://doi.org/10.3892/ol.2015.3995
- miRNA-24-3p promotes cell proliferation and regulates chemosensitivity in head and neck squamous cell carcinoma by targeting CHD5 vol.12, pp.23, 2016, https://doi.org/10.2217/fon-2016-0179